Reviews Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease – Open Access Curry, Daniel W. | Stutz, Bernardo | Andrews, Zane B. | Elsworth, John D. Progression of Cognitive Decline in Parkinson’s Disease – Open Access Roheger, Mandy | Kalbe, Elke | Liepelt-Scarfone, Inga Gene Therapy for Parkinson’s Disease, An Update – Open Access Axelsen, Tobias M. | Woldbye, David P.D. Research Articles Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson’s Disease Patients? A Systematic Review Katsaiti, Irene | Nixon, John Cognitive Rehabilitation in Parkinson’s Disease: A Systematic Review Alzahrani, Hamad | Venneri, Annalena What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis – Openly Available Athauda, Dilan | Maclagan, Kate | Budnik, Natalia | Zampedri, Luca | Hibbert, Steve | Skene, Simon S. | Chowdhury, Kashfia | Aviles-Olmos, Iciar | Limousin, Patricia | Foltynie, Thomas High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease Hogg, Elliot | Athreya, Kishore | Basile, Christina | Tan, Echo E. | Kaminski, Jan | Tagliati, Michele Impact of Subthalamic Deep Brain Stimulation Frequency on Upper Limb Motor Function in Parkinson’s Disease – Open Access Momin, Sheikh | Mahlknecht, Philipp | Georgiev, Dejan | Foltynie, Thomas | Zrinzo, Ludvic | Hariz, Marwan | Zacharia, Andre | Limousin, Patricia Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents – Open Access Polinski, Nicole K. | Volpicelli-Daley, Laura A. | Sortwell, Caryl E. | Luk, Kelvin C. | Cremades, Nunilo | Gottler, Lindsey M. | Froula, Jessica | Duffy, Megan F. | Lee, Virginia M.Y. | Martinez, Terina N. | Dave, Kuldip D. | Indexed in: PubMed/MEDLINE Scopus | Submit to JPD As a member of our research community, we invite you to contribute your own articles JPD. The journal has a quick turnaround of manuscripts, with a median time to first decision of just 3 days (average is 15 days). JPD offers contributing authors many benefits, including rigorous peer review and speedy manuscript processing, rapid online publication (pre-press) and an Open Access option. Submit your manuscript online via MsTracker View detailed Instructions to Authors Aims and Scope | Most Read JPD Articles in May 2018 Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents – Open Access (Review Article in Vol.8, Iss.2, 2018; was available in pre-press) Polinski, Nicole K. | Volpicelli-Daley, Laura A. | Sortwell, Caryl E. | Luk, Kelvin C. | Cremades, Nunilo | Gottler, Lindsey M. | Froula, Jessica | Duffy, Megan F. | Lee, Virginia M. Y. | Martinez, Terina N. | Dave, Kuldip D. Gene Therapy for Parkinson’s Disease, An Update – Open Access (Review Article in Vol.8, Iss.2, 2018; was available in pre-press) Axelsen, Tobias M. | Woldbye, David P.D. Provoking Freezing of Gait in Clinical Practice: Turning in Place is More Effective than Stepping in Place – Open Access (Letter in Vol.8, Iss.2, 2018; was available in pre-press) van Dijsseldonk, Karlijn | Wang, Ying | van Wezel, Richard | Bloem, Bastiaan R. | Nonnekes, Jorik Glucocerebrosidase Mutations in Parkinson Disease – Open Access (Review Article in Vol.7, Iss.3, 2017) O’Regan, Grace | deSouza, Ruth-Mary | Balestrino, Roberta | Schapira, Anthony H. Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies – Open Access (Research Article in Vol.6, Iss.3, 2016) Pagan, Fernando | Hebron, Michaeline | Valadez, Ellen H. | Torres-Yaghi, Yasar | Huang, Xu | Mills, Reversa R. | Wilmarth, Barbara M. | Howard, Hellen | Dunn, Connell | Carlson, Alexis | Lawler, Abigail | Rogers, Sean L. | Falconer, Ramsey A. | Ahn, Jaeil | Li, Zhaoxia | Moussa, Charbel | Delivered by JPD, Parkinson's Movement & CPT | As we announced in our mailing back in April (see here), we are pleased to be working in partnership with The Cure Parkinson’s Trust (CPT) to provide information about breaking research news to be featured on the new web portal for people with Parkinson’s (PwPs) called Parkinson’s Movement: parkinsonsmovement.com. One section of the site is dedicated to sifting through recent research in order to concisely capture a snapshot of the science and translate it to deliver better understanding for all. Assessing the impact of published PD-related research is done through a panel of experts, researchers and PwPs.The JPD scientific panel consists of JPD Editor-in-Chief Patrik Brundin and a number of members of the JPD Editorial Board. Linked to this initiative, a new series of Quarterly Parkinson's Webinars is to be launched – read more in our news item here. Inaugural Parkinson Webinar: June 19, 2018 This quarterly webinar series will bring the discussion of specific research topics into the open; the whole process of rating research will become even more transparent. The inaugural webinar will take place on June 19 in London, UK (5.30 pm BST, 12.30 pm EST) and the topic for discussion will be: “Does exenatide reduce non-motor symptoms in Parkinson’s disease?” The focus of the discussion will be a recent JPD article focusing on exenatide. The webinar will be chaired by Professor Patrik Brundin and joined by fellow panellists: Tom Foltynie from UCL in London, who let the exenatide trial; Nigel Greig and Dimitrios Kapogiannis from the NIA (National Institute on Aging); and exenatide trial participant Penny Kustow. Click the banner (below) to book your place or go here. | |